Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Proteostasis Therapeutics Inc. (PTI)

1.33   -0.01 (-0.75%) 07-10 16:00
Open: 1.34 Pre. Close: 1.34
High: 1.375 Low: 1.315
Volume: 678,806 Market Cap: 69M
Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat cystic fibrosis. The company's lead product candidates for the treatment of CF include PTI-801, a cystic fibrosis transmembrane conductance regulator (CFTR) corrector agent; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. It has collaboration agreements with Cystic Fibrosis Foundation, Inc. to research, develop, and commercialize products for the treatment of CF, non-classical CF, and other pulmonary diseases in the United States or the European Union; and Genentech, Inc. for licensing the technology and materials relating to therapeutic small molecule modulators. The company was formerly known as Proteoguard, Inc. and changed its name to Proteostasis Therapeutics, Inc. in September 2007. Proteostasis Therapeutics, Inc. was founded in 2006 and is headquartered in Boston, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.381 - 1.39 1.39 - 1.398
Low: 1.303 - 1.311 1.311 - 1.319
Close: 1.317 - 1.331 1.331 - 1.343

Technical analysis

as of: 2020-07-10 4:31:26 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.73     One year: 1.86
Support: Support1: 1.32    Support2: 1.09
Resistance: Resistance1: 1.48    Resistance2: 1.59
Pivot: 1.41
Moving Average: MA(5): 1.35     MA(20): 1.42
MA(100): 1.44     MA(250): 1.40
MACD: MACD(12,26): -0.04     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 13.96     %D(3): 16.21
RSI: RSI(14): 39.64
52-week: High: 4.72  Low: 0.61  Change(%): 35.4
Average Vol(K): 3-Month: 104230  10-Days: 79425

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTI has closed above bottom band by 18.1%. Bollinger Bands are 51.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTI's normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Sun, 05 Jul 2020
Are The Quant Signals for Proteostasis Therapeutics, Inc. (NasdaqGM:PTI) Telling a Positive Story? - Pineville

Thu, 02 Jul 2020
Proteostasis Therapeutics (NASDAQ:PTI) Downgraded by ValuEngine to Hold - Stock Market Daily

Thu, 25 Jun 2020
Proteostasis Therapeutics, Inc. (PTI) Is Worth A Look Now, Despite 212.58% Loss From High - Stocks Register

Thu, 25 Jun 2020
What Proteostasis Therapeutics, Inc. (PTI) Doesn’t Want You to Know - The News Heater

Thu, 18 Jun 2020
Where Does Wall Street Think Proteostasis Therapeutics Inc (PTI) Stock Will Go? - InvestorsObserver

Mon, 15 Jun 2020
Proteostasis Therapeutics Inc. (NASDAQ:PTI) Releases In Vitro PTI-129 Results As A possible COVID-19 Treatment Candidate - BP Journal

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 52
Shares Float (M) 44
% Held by Insiders 17.86
% Held by Institutions 22.55
Shares Short (K) 3,040
Shares Short P. Month (K) 2,800

Stock Financials

EPS -1.061
EPS Est This Year -2.750
EPS Est Next Year -2.450
Book Value (p.s.) 1.020
Profit Margin
Operating Margin
Return on Assets (ttm) -35.7
Return on Equity (ttm) -70.8
Qtrly Rev. Growth
Gross Profit (p.s.) 0.096
Sales Per Share
EBITDA (p.s.) -1.050
Qtrly Earnings Growth
Operating Cash Flow (M) -53
Levered Free Cash Flow (M) -32

Stock Valuations

PE Ratio -1.25
PEG Ratio
Price to Book value 1.30
Price to Sales
Price to Cash Flow -1.30

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.